NPC1L1 and steatosis: These results indicate that ezetimibe prevented the lipid accumulation in the livers of L1‐Tg mice fed a HFD, supporting the possibility that hepatic NPC1L1 exacerbates steatosis, and, thus, that ezetimibe could be useful in preventing steatosis.